Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck

Cancer Treat Rep. 1979 Mar;63(3):489-91.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Bleomycin / administration & dosage
  • Bleomycin / adverse effects
  • Bleomycin / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects
  • Cisplatin / therapeutic use*
  • Clinical Trials as Topic
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Head and Neck Neoplasms / drug therapy*
  • Humans
  • Male
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use*
  • Middle Aged

Substances

  • Bleomycin
  • Cisplatin
  • Methotrexate